Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4

被引:24
|
作者
Hardy, David [1 ,2 ]
Bill, Roslyn M. [1 ]
Jawhari, Anass [2 ]
Rothnie, Alice J. [1 ]
机构
[1] Aston Univ, Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[2] CALIXAR, 60 Ave Rockefeller, F-69008 Lyon, France
基金
英国生物技术与生命科学研究理事会;
关键词
ABC transporter; membrane protein expression; fluorescence; vesicular transport assay; BINDING CASSETTE TRANSPORTERS; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; P-GLYCOPROTEIN; MRP4; ABCC4; BACULOVIRUS; INSECT; OVEREXPRESSION; PURIFICATION;
D O I
10.1177/2472555219867070
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To study the function and structure of membrane proteins, high quantities of pure and stable protein are needed. One of the first hurdles in accomplishing this is expression of the membrane protein at high levels and in a functional state. Membrane proteins are naturally expressed at low levels, so finding a suitable host for overexpression is imperative. Multidrug resistance protein 4 (MRP4) or ATP-binding cassette subfamily C member 4 (ABCC4) is a multi-transmembrane protein that is able to transport a range of organic anionic compounds (both endogenous and xenobiotic) out of the cell. This versatile transporter has been linked with extracellular signaling pathways and cellular protection, along with conferring drug resistance in cancers. Here we report the use of MRP4 as a case study to be expressed in three different expression systems: mammalian, insect, and yeast cells, to gain the highest yield possible. Interestingly, using the baculovirus expression system with Sf9 insect cells produced the highest protein yields. Vesicular transport assays were used to confirm that MRP4 expressed in Sf9 was functional using a fluorescent cAMP analogue (fluo-cAMP) instead of the traditional radiolabeled substrates. MRP4 transported fluo-cAMP in an ATP-dependent manner. The specificity of functional expression of MRP4 was validated by the use of nonhydrolyzable ATP analogues and MRP4 inhibitor MK571. Functionally expressed MRP4 in Sf9 cells can now be used in downstream processes such as solubilization and purification in order to better understand its function and structure.
引用
收藏
页码:1000 / 1008
页数:9
相关论文
共 50 条
  • [41] Expression, localization and function of the nucleotide transporter MRP4 (ABCC4) in human platelets
    Jedlitschky, G
    Tirschmann, K
    Lubenow, LE
    Schuster, K
    Greinacher, A
    Kroemer, HK
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R1 - R1
  • [42] Release of Platelet-Derived Sphingosine-1-Phosphate Involves Multidrug Resistance Protein 4 (MRP4/ABCC4) and Is Inhibited by Statins
    Vogt, Katja
    Mahajan-Thakur, Shailaja
    Wolf, Robert
    Broderdorf, Susanne
    Vogel, Conny
    Boehm, Andreas
    Ritter, Christoph A.
    Graeler, Markus
    Oswald, Stefan
    Greinacher, Andreas
    Kroemer, Heyo K.
    Jedlitschky, Gabriele
    Rauch, Bernhard H.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 132 - 142
  • [43] MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease
    Belleville-Rolland, Tiphaine
    Sassi, Yassine
    Decouture, Benoit
    Dreano, Elise
    Hulot, Jean-Sebastien
    Gaussem, Pascale
    Bachelot-Loza, Christilla
    PHARMACOLOGICAL RESEARCH, 2016, 107 : 381 - 389
  • [44] Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity
    Wittgen, Hanneke G. M.
    van den Heuvel, Jeroen J. M. W.
    Krieger, Elmar
    Schaftenaar, Gijs
    Russel, Frans G. M.
    Koenderink, Jan B.
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (03) : 366 - 373
  • [45] Functional analysis of multidrug resistance protein 4 (MRP4) in renal proximal tubules
    Reichel, V
    Miller, DS
    Masereeuw, R
    Fricker, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R4 - R4
  • [46] Functional characterization of protein variants of MRP1 (ABCC1), MRP2 (ABCC2) and MRP4 (ABCC4) in Xenopus laevis oocytes
    Lang, T
    Janke, D
    Gödtel-Armbrust, U
    Habermeier, A
    Fromm, MF
    Closs, E
    Wojnowski, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 18 - 18
  • [47] The multidrug transporter MRP4/ABCC4 is a powerful marker of poor prognosis in neuroblastoma and a target for therapeutic suppression
    Norris, M. D.
    Smith, J.
    Flemming, C.
    Lyn, L.
    Allen, J.
    Cohn, S. L.
    London, W. B.
    Buxton, A.
    Marshhall, G. M.
    Haber, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 121 - 121
  • [48] Regulation of the basal promoter activity of the human MRP4 (ABCC4) transporter
    Kragl, A.
    Ziems, K.
    Glaubitz, J.
    Grammbauer, S.
    Broederdorf, S.
    Cole, S. P. C.
    Tzvetkov, M. V.
    Jedlitschky, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S37 - S37
  • [49] Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney
    Ci, Lei
    Kusuhara, Hiroyuki
    Adachi, Masashi
    Schuetz, John D.
    Takeuchi, Kenji
    Sugiyama, Yuichi
    MOLECULAR PHARMACOLOGY, 2007, 71 (06) : 1591 - 1597
  • [50] A Role For a Multi-Drug Resistance Protein (MRP4/ABCC4) In Pediatric Acute Myeloid Leukemia (AML)
    Lian, Shang Li
    Wang, Yao
    Zhou, Sheng
    Sukthankar, Mugdha
    Neale, Geoffrey A.
    Downing, James R.
    Schuetz, John D.
    BLOOD, 2013, 122 (21)